Detalhe da pesquisa
1.
International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience).
Aesthet Surg J
; 44(2): 192-202, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490767
2.
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
Aesthetic Plast Surg
; 47(1): 351-364, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536093
3.
Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
Dev Med Child Neurol
; 63(5): 592-600, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33206382
4.
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.
Aesthet Surg J
; 40(9): 1000-1008, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31550352
5.
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Aesthet Surg J
; 40(1): 93-104, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30893430
6.
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
Muscle Nerve
; 57(2): 245-254, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28590525
7.
Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
Aesthetic Plast Surg
; 47(3): 1243, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951993
8.
Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial.
Aesthet Surg J
; 38(2): 183-191, 2018 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28200002
9.
Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study.
Neurourol Urodyn
; 36(2): 457-462, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26756554
10.
Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
Mov Disord
; 31(11): 1649-1657, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27653448
11.
Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Aesthet Surg J
; 41(11): 1338, 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739363
12.
Response to "Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance".
Aesthet Surg J
; 40(12): NP708-NP709, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32960940
13.
AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies.
J Neural Transm (Vienna)
; 120(2): 299-307, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878514
14.
Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA.
Int J Neurosci
; 122(7): 358-62, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22356470
15.
When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
Brain Commun
; 3(1): fcaa201, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33543139
16.
The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury.
PM R
; 13(5): 488-495, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741133
17.
Histomorphology and vascular lesions in dorsal rat skin used as injection sites for a subcutaneous toxicity study.
Toxicol Pathol
; 38(2): 258-66, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20100843
18.
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies.
Front Neurol
; 11: 576117, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33101184
19.
Abobotulinumtoxina injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.
J Rehabil Med
; 52(6): jrm00068, 2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451555
20.
Onset and Duration of AbobotulinumtoxinA for Aesthetic Use in the Upper face: A Systematic Literature Review.
J Clin Aesthet Dermatol
; 13(12): E56-E83, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33488922